Study title: Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. J Dermatolog Treat. 2009;20(3):141-5.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Azathioprine | |||||
ATC code: L04AX01 | |||||
Document link: | |||||
Document date: 2015-04-14 | |||||
Study number: PMID: 18951236 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |